The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- Cross River targets commercial livestock sector for jobs, investment
- State police: NASS sends bill to 36 Assemblies, sets 30-day response window
- WFP prioritises women farmers for Nigeria’s prosperity
- PAN to sustain partnership with NPC despite chairman’s death
- Shettima holds northern governors in high regard — Nkwocha
- LUTH cardiologist urges safe care for NCD patients
- FG seeks tougher wildlife crime sanctions
- King Charles warns of AI risks
